Surviving Lymphoma: Early Detection Is An Important Factor

Lymphoma is a life-threatening disease, but is very treatable in most cases. The 5-year survival for patients diagnosed with non-Hodgkin's lymphoma is 71% and the 5-year survival rate for patients diagnosed with Hodgkin's Lymphoma is 86%.

This number is an average and varies widely depending on variables including the age of a patient, the stage of the disease (i.e., how far it has advanced), the patient's overall health and socioeconomic status. Generally speaking, however, lymphoma treatment and survival rates are improving.

As with any cancer, early detection of lymphoma is the single most important factor in a successful outcome.

After the Diagnosis

Following diagnosis, there are multiple treatment options and significant consultations and even experimentation might be required to find the best treatment for a given patient.

A positive mental outlook is also important as depression can interfere with a lymphoma patient's ability to respond to and recover from treatment. Depression will decrease an individual's motivation to follow through with therapy, medication, and other patient-dependent aspects of recovery.

LymphomaInfo.net offers many pages that lead the way to a better understanding of lymphoma detection, symptoms and treatment. Whether you have been recently diagnosed with lymphoma or have completed treatment, we connect you with other patients and survivors of Hodgkin and non-Hodgkin lymphomas. Whether you need general information or are looking for specific products such as medical ID bracelets, a community to provide information and support should be seen as an essential component of any recovery effort.

Lymphoma Survivor Support and Issues

Source: Healthline, MedicineNet
Photo: Pexels

More Articles

More Articles

Amazon.com is pleased to have the Lymphoma Information Network in the family of Amazon.com associates. We've agreed to ship items...

The question ought to be what are myelodysplastic syndromes (MDS), since this is a group of similar blood and bone marrow diseases that...

Merkel Cell Carcinoma (MCC) is a very rare and aggressive skin cancer that usually develops when a person is in his or her 70s. It is...

Radiation Therapy Topics

...

At some point, the Seattle biotech company Cell Therapeutics Inc (CTI) should earn an entry in the Guinness Book of World Records for utter and...

Site Beginnings

This site was started as Lymphoma Resource Page(s) in 1994. The site was designed to collect lymphoma...

Three papers appearing in the journal Blood and pointing towards a regulator-suppressor pill could offer hope to blood cancer...

The US Food and Drug Administration (FDA) has granted a third so-called Breakthrough Therapy Designation for the investigational oral...

The US Food and Drug Administration today has approved an expanded use of Imbruvica (ibrutinib) in patients with...

The U.S. Food and Drug Administration has announced that it has granted "Breakthrough Therapy Designation" for the investigational agent...

According to a new study published in the Proceedings of the National Academy of Sciences, a team from the University of California, San...

Pharmacyclics has announced that the company has submitted a New Drug Application (NDA) to the US Food and Drug Administration (FDA) for...

New research suggests that frontline radioimmunotherapy...

Gilead Sciences has announced results of the company's Phase II study of its investigational compound idelalisib, an oral inhibitor of...

Sitemap